Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yeah, I thought dub 25s were a smoking deal so I increased my position to a half mill.
Looks like I gave it my typical kiss of death. Sorry.
Had some spare coin to make my entry here and get today’s trading going. Will add as able.
I would greatly appreciate that :)
Had a few bucks left over last week so I made my very modest $VIBI entry with 15K shares. Added 110K at open this morning and freed up some more funds for that 225 slap right before close.
I’m more of a lurker than a poster but happy to get in before launch.
As you wish. This is the latest (and only) $LLBO news that I’m currently seeing on Fidelity for the record:
Lifeline Biotechnologies, Inc. Updates Current Shareholders and the Public
BY GLOBENEWSWIRE — 02/19/2019
Reno, Nevada, Feb. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- We are pleased to share current information and developments with our stakeholders and the public, February 19, 2019.
Regarding Lifeline’s investment in Cyrcadia, Inc. (CI), CI’s largest shareholder at approximately 35%, Cyrcadia has reported the resumption of its clinical studies at El Camino Hospital (ECH) in Mountain View, CA. The resumption of the studies is the result of improvements to both the iTBra system (hardware and application interface) and improvement of the underlying predictive analytics. The objective and result of the improvements yield a system capable of acquiring patient data in a far reduced wear time, 6 hours vs. 24 hours, a low energy Bluetooth communications system, and a design of the hardware intended for ease of use comfort and transfer to manufacturing for eventual commercialization.
The design, development and commercial grade improvements have been performed by Jabil, a world leader in medical device design and engineering, under a contract with Cyrcadia’s licensee company, Hong Kong based, Cyrcadia Asia (CA). Cyrcadia Asia is supplying CI with product for the resumption and completion of this round of studies.
CI has recently returned from a site visit at ECH, to “kick off” the study resumption, reporting a very energetic and eager response from the primary investigator and referring physician at the site. Continued enrollment is expected by late March to early April 2019.
Following the enrollment at ECH, CI will then move to continuation of studies at its other clinical site, Ohio State University. Enrollment of both sites, along with the usability improvements to the CDR-100 system (potentially branded the iTBra) is expected to rapidly accelerate enrollment for completion of the study. The statistical requirement for validation of the study is 173 patients. The study has already achieved enrollment and completion of the initial 66 cases with a balance of 107 to complete. CI’s expectation of accelerated enrollment is based on the reduced wear-time along with broader regional outreach at both site locations.
Additionally, CI is preparing for a potential pre-submission meeting with the FDA to ensure regulatory adherence with the intent of achieving marketing clearance. Upon FDA acceptance of the meeting, CI expects to meet with the FDA in approximately 90 days yielding clear guidance for marketing approval.
Cyrcadia is also currently designing a Pilot Program as a usability and market testing study. The strategy is to contract a number of women’s health clinics throughout the US under a similar protocol to the clinical studies, placing the system in physicians’ hands at “real-world” clinics. The objectives are to gauge user feedback and refine the marketing strategy. Though the Pilot Program is being designed, it will not take place until the company has acceptance by the FDA.
The intended result of these activities is to accelerate CI’s drive to possible significant value via generation of revenue by the end of 2019 or early 2020, through sales directly to physician clinics (based on information obtained from the Pilot Program), leading to a possible merger or acquisition potentially some time in 2020. It must be noted that the iTBra system has not yet been cleared by the FDA for marketing in the United States.
Just copied this same article on Fidelity and was about to post it.
“The bitcoin price rise comes as bitcoin daily trading volume tops $11 billion, the most seen in a 24-hour period since last April, when the bitcoin price was trading at over $8,000.”
Great domain, nice simple site, products, revenue incoming...
https://www.infusional.com/
Wanderport Gearing Up to Support Recent Upsurge in Sales of Sapa Hemp and CBD Coffee and Tea Following the Signing of Farm Bill
https://finance.yahoo.com/news/wanderport-gearing-support-recent-upsurge-133000145.html
Avinger’s Pantheris SV (Small Vessel) Featured in Live Case Transmission at Leipzig Interventional Course (LINC) 2019
https://finance.yahoo.com/news/avinger-pantheris-sv-small-vessel-130000281.html
Clovis' Rubraca Gets Nod as Maintenance Therapy in Europe
https://finance.yahoo.com/news/clovis-rubraca-gets-nod-maintenance-120212809.html
CBD OF DENVER, INC. (CBDD) Confirms Second Product Release
https://finance.yahoo.com/news/cbd-denver-inc-cbdd-confirms-132400503.html
Elev8 Brands, Inc. Acquires Blessed Bean Coffee, LLC
https://finance.yahoo.com/news/elev8-brands-inc-acquires-blessed-133000022.html
Tequila Comisario will be the “Official Tequila” at Sundance Film Festival and Bud Light Super Bowl Music Fest
https://finance.yahoo.com/news/tequila-comisario-official-tequila-sundance-133000062.html
2 short paragraphs with a lot of wisdom in each.
Just realized tomorrow is only Thursday so scratch the beer money comment. Still have my days all messed up from the holidays.
I made my very modest entry last Friday at .0015 - considered moving some of my turds here for a bigger position, but didn’t. Really regretting that now.
I don’t expect a beer money selloff tomorrow, but will definitely free up some powder early in case there is.
Elev8 Brands, Inc. Begins Production of New CBD Bottled and Canned Beverages
https://finance.yahoo.com/news/elev8-brands-inc-begins-production-133000306.html
Nice. Here’s what Google Translate gave me for a 12/23 post. Forgive if already posted here; didn’t see it:
“Co-sponsored by the US Donation Foundation Service & Sharing (JWC) & World Praise Festival Organizing Committee (OFT coin) Praise for the donation Coin has signed agreements with the World Martial Arts Federation (FMC) and the Korea Martial Arts Promotion Foundation You can use it as a substitute coin for substitution and martial arts games.”
From what I saw yesterday morning, it appeared that Fidelity people (myself and only one other post that I read) were the first to show our shares split.
(I went to sleep Thursday night with 10,000 shares; woke up yesterday morning with 18!)
10,000/18 = 555.5555
As of this moment (6:40AM Pacific Time, Saturday 12/22), Fidelity is still showing the PPS as .12 (+1,353.49%).
I thought that the Fidelity PPS might have updated overnight, but nothing yet. Hopefully that will happen Monday morning before market opens - and the markets close 3 hours early on Monday just to get that in here.
IF it is adjusted for everyone, is it safe to assume that it will be yesterday’s closing price (.125) x 553?
(Or the Fidelity numbers, .12 x 555?)
Either way, we’d be looking at an open of nearly $70/share.
Again, IF that happens I assume that price would plummet quickly, but who knows? If we sit on top of the BOB all weekend and newcomers see yesterday’s 1300% gain (along with the presumed reduced float), this thing could REALLY go nuts, no?
These are just questions/guesses and I may not know WTF I’m talking about. This whole thing has been bizarre and fascinating. Very curious to find out where we end up.
Looks like it was on Nov. 23 per my post #1340 if that helps.
My 10,000 shares are now 18 in Fidelity. R/S done.
I planned on adding a bunch to avg. down today. Guess that’s not gonna happen.
Nice. Exactly how many I have. But you paid $400; mine cost me $1,855.
Eff Emm Ell.
Hope this news generates a little activity here:
https://globenewswire.com/news-release/2018/11/28/1658233/0/en/Beta-Music-Group-Inc-BEMG-Introduces-Revolutionary-Lead-Recovery-Platform.html
I tried repeating this transaction today, but no dice.
Settled for 10K @ .03. Oh well; got my foot in the door.
Was trying for cheapies & decided to slap the ask with 3 seconds to spare. Unintentional paint job.
Yeah, I just received a price trigger alert that I set a while back in Fidelity. Will be keeping a close eye on this one.
Just dropped in to say the same. If this thing gets eyes on it over the weekend, it can go ballistic on Monday+.
Seems to be getting a little attention now. Could pick up a lot of steam if it keeps up.
Auxly Buys 80% of CBD Producer in Uruguay for US$15 Million
https://www.newcannabisventures.com/auxly-buys-80-of-cbd-producer-in-uruguay-for-us15-million/
Fidelity shows no price either, but I've had a couple small sells go through so I think it's fine - guessing we won't see a price until tomorrow though. It does show a bid & ask when I click on Get Quote.
Now #14. Movin’ on up!
I’m down thousands on numerous POS plays I’ve made this year, but now up 162% on the measly 10K $KGKG shares I bought a couple months ago. I think I’m doing this wrong.
Mining Right Application for Waterberg PGM Project Accepted
http://www.platinumgroupmetals.net/investor-relations/news/press-releases/press-releases-details/2018/Mining-Right-Application-for-Waterberg-PGM-Project-Accepted/default.aspx
News:
The Company expands to three new locations
https://finance.yahoo.com/news/company-expands-three-locations-123000612.html
Great day. Patience finally paying off here.
MagneGas Announces Launch of Phase II of USDA Grant-Funded Sterilization Project
https://finance.yahoo.com/news/magnegas-announces-launch-phase-ii-120000862.html